The Health Information and Quality Authority (HIQA) is involving public and/or patient (PPI) representatives in the development of its National Standards for Children’s Social Services. Its aim is to gain insights from people using services as to…
The project to engage the public on the collection, use and sharing of health information started in 2019 and concluded in June 2021 and it involved public and/or patient representatives at various stages across its lifecycle in order to gain a…
The National Centre for Pharmacoeconomics (NCPE) – in partnership with IPPOSI – has designed a six week module on the health technology assessment process to provide patients participating in the IPPOSI Patient Education Programme with…
The Health Research Consent Declaration Committee (HRCDC) was established as part of the Health Research Regulations under the Data Protection Act of 2018. The purpose of these regulations is to support health research and promote necessary and…
The National Clinical Effectiveness Committee (NCEC) was established in 2010, as a partnership of patient safety stakeholders. Its mission is to provide the framework for the national endorsement of clinical guidelines and audit to optimise patient…
The Irish Heart Attack Audit (IHAA) Governance Committee was established in 2019, after responsibility for the audit of Acute Coronary Syndrome (ACS) care was transferred to the National Office for Clinical Audit (NOCA). The PPI representatives…
The National ICU Audit (INICUA) Governance Committee was established in 2013. The Committee collects and reviews health data to complete clinically-led audit of patient care and outcomes in adult and paediatric ICUs. The PPI representatives…
The Irish National Audit of Stroke (INAS) Governance Committee was established in 2019. It comprises of 17 members, of which two are public and/or patient (PPI) representatives. The role of the public and/or patient (PPI) representatives is equal to…
The National Research Ethics Committee (NREC) for COVID-19 was the first National Research Ethics Committee (NREC). It was established in early 2020 to deliver a fast-tracked review process for COVID-19 related health research. The National Research…
The Health Research Board (HRB) involved two public reviewers in allocating funding under the Patrick Quinn scheme. Given the condition-specific nature of the available funding, both reviewers were family members/carers of patients with Parkinsons.…
The Health Research Board (HRB) involves public reviewers in the process of reviewing applications for funding to various HRB schemes. In 2019, public reviewers were invited to share their feedback on applications made to two post-doctoral…
The HPRA is committed to widening its engagement with patients and patient organisations, to enable a deeper understanding of patient perspectives and experiences in relation to the regulation of health products. The Health Products Regulatory…
The expert advisory group for this health technology assessment (HTA) was established to assess the clinical and economic impact of transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis…
The expert advisory group for this health technology assessment (HTA) was established to assess the clinical and economic impact of a pre-exposure prophylaxis (PrEP) programme for populations at substantial risk of sexual acquisition of HIV. The…
The expert advisory group for this health technology assessment (HTA) was established to assess the clinical and economic impact of providing C-reactive protein point-of-care testing to inform the prescribing of antibiotics for patients presenting…
The Health Information and Quality Authority (HIQA) involved public and/or patient (PPI) representatives in the development of its recommendations for the implementation of a electronic patient summary record in Ireland in order to gain a greater…
The National Care Experience Programme (NCEP) seeks to improve the quality of health and social care services in Ireland by asking people about their experiences of care and acting on their feedback. It is a joint initiative by the Health…
The Health Research Board (HRB) involved two public reviewers in allocating funding under the HRB-HRCI joint scheme. The public reviewers were engaged from May-June 2020. The four public reviewers were selected from the Health Research Board’s…
MSD has engaged patient representatives to learn more about their lived experience. In May 2019, one patient was invited to speak at an MSD lung conference. From April to June 2019, MSD invited 10 patient representatives to participate in a series…
Novartis engages patient representatives to learn more about their lived experience via a mechanism known as Patient Advisory Boards. Advisory Boards are established as and when they are needed and focus on exploring a specific topic or condition.…



